GL1X · GenesisL1 explorer

MolNFT v1 · #76514 · protein

Potent and selective bicyclic peptide inhibitor (UK18) of human urokinase-type plasminogen ACTIVATOR(UPA)

3QN7: “Potent and selective bicyclic peptide inhibitor (UK18) of human urokinase-type plasminogen ACTIVATOR(UPA)”. X-ray diffraction, 1 ligand (ZBR), 1 pocket (best druggability 0.50). MolNFT v1 #76514 on GenesisL1: 3D structure, binding…

PDB
3QN7
Type
protein
Length
261 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator; Bicyclic peptide inhibitor
EC
3.4.21.73
UniProt
P00749
Ligands
ZBR
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activator (EC 3.4.21.73)protein2459% helix, 39% strandP00749
BBicyclic peptide inhibitorprotein160% helix, 0% strand—

Ligands and binding sites

  • ZBR · 1,3,5-tris(bromomethyl)benzene · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.500.8821ZBR

Interfaces

1 interface between chains.

  • A–B · 829 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 3 covalent (disulfide, covalent ligand).

Compared structures

  • 3QN7 · Potent and selective bicyclic peptide inhibitor (UK18) of human urokinase-type… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.